| mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
-0.083 |
0.05 |
| mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.05 |
| mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.05 |
| mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
| mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.05 |
| mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.07 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.07 |
| mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.07 |
| mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.07 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.07 |